生物成分产业，全球市场 2025-2030

人乳寡糖(HMO) 后生元研究及产品开发进展推动转型成长

近年来，由于益生菌、益生元和后生元领域的技术快速进步，生物製品产业发生了重大转变。

消费者对益生菌益处的认识、技术创新以及欧洲有利的监管发展正在推动这一领域的成长。提高消费者对高纤维饮食治疗益处的认识是益生元成长的关键动力。 2021 年，国际益生菌和益生元科学协会发布了后生元的共识定义，为研究人员和产业相关人员提供更清晰的解释。这将推动后生元领域的产品创新和市场扩张。

虽然益生菌和益生元仍然是生物成分产业的关键组成部分，但由于后生元拥有强大的技术参数，并且先进的研究正在揭示其在肠道和免疫健康之外的潜力，预计后生元领域将在预测期内推动最大的成长。

根据应用，由于益生元在行业中的大量使用，预计在预测期内微生物友好型机能性食品和饮料将需要最多量的生物成分。另一个原因是研究的进步和製造商提供创新的生物成分，例如后生元和产孢益生菌。

从地理位置来看，亚太地区在生物成分需求方面占据主导地位，这得益于消费者对预防性医疗保健的认识、可支配收入的增加、经济的快速增长以及有利的法规环境。北美和欧洲是生物製药，因为北美消费者在膳食补充剂上的支出很高，而欧洲的食品和饮料行业规模庞大。

Frost & Sullivan 在本报告中涵盖了五个地区。北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。研究期间为2022年至2030年，以2024年为基准年，2025年至2030年为预测期间。

收益预测

2022 年基准年收益预估为 58.461 亿美元，2022-2030 年研究期间复合年增长率为 6.5%。

主要竞争对手

益生菌

• ADM
• Biena
• BioGaia
• Biosearch Life
• Cerbios Pharma
• Clerici-Sacco Group
• Daflon
• Danin International
• dsm-firmenich
• Gnosis by Lesaffre
• IFF
• Jiangsu Wecare Biotechnology Co., LTD.
• Kaneka Probiotic
• Lab4 Probiotic
• Lallemand
• Morinaga Milk Industry Co. Ltd.
• Natren
• Nova
• Novozymes
• NZMP
• Probi

益生元

• Abbott Laboratories
• ADM
• Anderson Advanced Ingredients
• BASF
• Beneo GMBH
• BioNeutra
• Biosynth
• Carbiotix
• Cargill
• Clasado Biosciences
• Cosucra
• Dextra Laboratories
• dsm-firmenich
• Elicylt SA
• Fonterra (NZMP)
• FrieslandCampina Ingredients
• Fuji Nihon Seito Corporation
• Galam
• GeneChem
• Gnubiotic Sciences SA
• Grain Processing Corporation
• IFF

后生元

• ADM
• Asahi Group
• Bereum
• dsm-firmenich
• Glac Biotech Co Ltd
• Humana Spain SL
• IDLONG Bioscience Co. Ltd
• Kerry
• Kyowa Hakko (Kirin Holdings Co., Ltd.)
• Morinaga Milk Industry Co. Ltd.
• Novozymes
• Sabinsa
• Synformulas
• SynBalance

目录

成长环境：生物原料产业的转型

• 为何成长变得越来越困难？
• The Strategic Imperative 8
• 三大策略要务对生物原料产业的影响

生物原料产业生态系统

• 什么是微生物群？
• 微生物群在人类健康中的作用
• 肠道微生物组产业生态系统
• 分析范围
• 按成分细分
• 市场定义：生物成分
• 市场定义：益生菌成分
• 市场定义：益生元成分
• 市场定义：后生元成分
• 定义应用程式

价值链

竞争环境

主要竞争对手

• 竞争基准化分析：益生菌成分
• 竞争基准化分析：益生元成分
• 竞争基准化分析：后生元成分
• 益生菌成分：主要製造商的市场活动，2022-2024 年
• 益生元成分：主要製造商的市场活动，2022-2023 年
• 益生元成分：主要製造商的市场活动，2022-2024 年
• 后生元成分：主要製造商的市场活动，2023-2024 年

生物成分产业的成长要素

• 成长指标
• 驱动程式
• 驱动因素分析
• 成长抑制因素
• 生长抑制分析
• 合成生物产业聚焦
• 市场趋势
• 预测性观察
• 收益预测
• 按产品类型预测收益
• 各地区收益预测
• 亚太地区各国收益预测
• 定价分析与预测假设
• 竞争格局

生长促进剂：益生菌成分

• 成长指标
• 益生菌简介
• 益生菌价值链
• 收益预测
• 收益预测分析
• 按组件分類的收益预测
• 各组件收益预测分析
• 按应用预测收益
• 按应用分類的收益预测分析
• 按健康福利预测收益
• 按健康收益分類的收入预测分析
• 各地区收益预测
• 亚太地区各国收益预测
• 各地区收益预测分析

生长发生器：益生元成分

• 成长指标
• 益生元简介
• 了解纤维与益生元
• 益生元价值链
• 收益预测
• 收益预测分析
• 按组件分類的收益预测
• 各组件收益预测分析
• 按应用预测收益
• 按应用分類的收益预测分析
• 按健康福利预测收益
• 按健康收益分類的收入预测分析
• 各地区收益预测
• 亚太地区各国收益预测
• 各地区收益预测分析

生长促进剂：后生元成分

• 后生元简介
• 后生元价值链
• 成长指标
• 收益预测
• 收益预测分析
• 按应用预测收益
• 按应用分類的收益预测分析
• 按组件分類的收益预测
• 按健康福利预测收益
• 按成分和健康益处进行的收益预测分析
• 各地区收益预测
• 亚太地区各国收益预测
• 各地区收益预测分析

生物原料产业的成长机会领域

• 成长机会1：后生元作为成长型产品类型
• 成长机会二：益生元产品创新
• 成长机会三：拓展广泛的治疗领域

附录：后续步骤

• 成长机会的益处和影响
• 后续步骤Next steps
• 附件列表
• 免责声明

Research and Product Development Advances in Human Milk Oligosaccharides and Postbiotics are Driving Transformational Growth

The biotics industry has witnessed a remarkable transformation in recent years, driven by rapid innovations in each biotics segment: probiotics, prebiotics, and postbiotics.

Consumer awareness of probiotic benefits, innovations, and favorable regulatory developments in Europe drive the segment's growth. Increasing consumer awareness of the therapeutic benefits of a high-fiber diet is a crucial growth propeller for prebiotics. In 2021, the International Scientific Association for Probiotics and Prebiotics published the consensus definition of postbiotics, which enhanced clarity for researchers and industry stakeholders. This drives product innovation and market expansion in the postbiotics space.

While probiotics and prebiotics remain vital components of the biotic ingredients industry, the postbiotics segment will likely drive the most growth during the forecast period due to its strong technical parameters and as research continues to unveil their potential beyond gut and immune health areas.

By application, microbiome-friendly functional food and beverages will demand the most biotic ingredients during the forecast period due to the substantial use of prebiotics in the industry. Another reason is advancements in research and innovative biotic ingredient offerings by manufacturers, such as postbiotics and spore-forming probiotics.

Geographically, Asia-Pacific dominates the demand for biotic ingredients because of consumer awareness of preventive healthcare, increasing disposable income, fast-growing economies, and favorable regulatory environment. North America and Europe are the other major markets for biotic ingredients due to high consumer spending on dietary supplements in North America and the massive food and beverage industry in Europe.

Frost & Sullivan covers 5 regions in this report: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The study period is 2022 to 2030, with 2024 as the base year and 2025 to 2030 as the forecast period.

Revenue Forecast

The revenue estimate for the base year 2022 is $5,846.1 million with a CAGR of 6.5% for the study period from 2022 to 2030.

The Impact of the Top 3 Strategic Imperatives on the Biotic Ingredients Industry

Geopolitical Chaos

WHY

• Despite inflationary pressures, the demand for biotic ingredients remained strong from 2022 to 2024.
• For example, Chr. Hansen (now Novozymes), a probiotics market leader, reported a 17% organic sales growth in health and nutrition sector in 2022. This indicates a rebound in consumer interest in probiotic supplements following the COVID-19 pandemic.
• Similarly, leading prebiotics manufacturer Beneo found that consumers prioritize product efficacy and proven health claims over price when choosing prebiotic products, even amid rising living expenses.

FROST PERSPECTIVE

• Companies in this market will need to remain wary of inflationary pressure by offering reliable and science-backed claims to sustain premium positioning even in challenging financial times.

Disruptive Technologies

WHY

• The biotics industry still faces formulation challenges in the more established product categories of viable and non-spore-forming probiotics. Currently, the most compelling innovations in the industry that can combat these challenges are prebiotics and spore-forming probiotics.
• Prebiotics manufacturers focus on reducing dosage requirements to develop more novel formats; for instance, OptiBiotix offers Opti005, and FrieslandCampina offers Biotis(R) GOS-OP High Purity. Both ingredients can significantly increase the beneficial gut microbial load at low dosages.

FROST PERSPECTIVE

• Disruptive new technologies can overcome the challenges associated with established biotics industry products. However, research is necessary to scientifically back claims of health benefits. Ingredient manufacturers should continue prioritizing R&D to support product innovations and formulations.

Transformative Megatrends

WHY

• Several megatrends are having a transformative impact on the biotics industry. Artificial intelligence (AI) is transforming all industries, and this is no different. The human microbiome is incredibly complex, and the use of AI-driven systems to identify, characterize, and research microbial strains is likely to gain momentum in the probiotics and postbiotics space.
• Personalization is a rapidly growing trend in the nutrition industry. Personalization technology is gaining momentum in the biotics industry, with microbiome testing kits, tailored probiotics, and AI-assisted programs offering consumers customized solutions.

FROST PERSPECTIVE

• All these megatrends can potentially disrupt existing market participants and present significant opportunities for growth.
• To stay competitive and meet the demand for innovative and effective solutions, options available to companies include investing in technology advancements, using data for personalized products, and developing new services.

Scope of Analysis

• The research scope includes biotic ingredients like probiotics, prebiotics, and postbiotics that help maintain a healthy human microbiome and prevent the growth of pathogenic microorganisms.
• The study's geographic scope is global and includes the following regions:
• North America: The United States and Canada
• Europe: European Economic Area and European Trade Association states, including the United Kingdom
• Asia-Pacific (APAC): China, Japan, South Korea, Australia, New Zealand, Association of Southeast Asian Nations (Indonesia, Thailand, Singapore, Malaysia, and the Philippines), and South Asian countries (India, Pakistan, Bangladesh, Sri Lanka, and Nepal); country-level segmentation for Asia-Pacific is included in the research scope for each biotic ingredient
• Latin America (LATAM): All LATAM countries, including Mexico
• Middle East and Africa (MEA): Africa and all Middle Eastern countries, including Turkey

The study analyzes each biotic ingredient type with respect to application, health benefits, and region. The scope and segmentation of application and health benefits vary for each type of biotic ingredient, depending on its market landscape.

Probiotics segmentation

By application: Dietary supplements, functional food and beverages, infant nutrition, medical food, and pharmaceuticals

By health benefit: Gut/Digestive health, immune health, brain health, metabolic health, beauty-from-within, sports nutrition, women's health (vaginal and urinary health, reproductive health), bone and joint health, and others (oral and eye health)

Prebiotics segmentation

By application: Dietary supplements, functional food and beverages, infant nutrition, and medical food

By health benefit: Gut/Digestive health, immune health, brain health, metabolic health, beauty-from-within, sports nutrition, women's health (vaginal and urinary health, reproductive health), and bone and joint health

Postbiotics segmentation

By application: Dietary supplements, functional food and beverages, infant nutrition, and pharmaceuticals

By health benefit: Gut/Digestive health, immune health, brain health, metabolic health, and others (women's health, eye health, and beauty-from-within)

Key Competitors

Probiotics

• ADM
• Biena
• BioGaia
• Biosearch Life
• Cerbios Pharma
• Clerici-Sacco Group
• Daflon
• Danin International
• dsm-firmenich
• Gnosis by Lesaffre
• IFF
• Jiangsu Wecare Biotechnology Co., LTD.
• Kaneka Probiotic
• Lab4 Probiotic
• Lallemand
• Morinaga Milk Industry Co. Ltd.
• Natren
• Nova
• Novozymes
• NZMP
• Probi

Prebiotics

• Abbott Laboratories
• ADM
• Anderson Advanced Ingredients
• BASF
• Beneo GMBH
• BioNeutra
• Biosynth
• Carbiotix
• Cargill
• Clasado Biosciences
• Cosucra
• Dextra Laboratories
• dsm-firmenich
• Elicylt S.A
• Fonterra (NZMP)
• FrieslandCampina Ingredients
• Fuji Nihon Seito Corporation
• Galam
• GeneChem
• Gnubiotic Sciences S.A
• Grain Processing Corporation
• IFF

Postbiotics

• ADM
• Asahi Group
• Bereum
• dsm-firmenich
• Glac Biotech Co Ltd
• Humana Spain S.L.
• IDLONG Bioscience Co. Ltd
• Kerry
• Kyowa Hakko (Kirin Holdings Co., Ltd.)
• Morinaga Milk Industry Co. Ltd.
• Novozymes
• Sabinsa
• Synformulas
• SynBalance

Growth Drivers

Research innovations drive the evolution of the gut microbiome industry.

Rising consumer awareness about probiotic benefits, innovations, and favorable regulatory developments in Europe drive the market growth of probiotics.

Increasing awareness of a high-fiber diet linked to therapeutic benefits among consumers is a key growth propeller for prebiotics.

ISAPP's publication of the consensus definition of postbiotics enhanced clarity for researchers and industry stakeholders, driving product innovation and market expansion.

Changes in government policies in China boost demand for biotic ingredients.

Growth Restraint

Biotic Ingredients: Growth Restraints, Global, 2025-2030

• The declining birth rate globally and frequent infant formula recalls in the United States impact the growth of the infant nutrition industry and the demand for biotic ingredients.
• The lack of harmonized regulation for biotic ingredients in EU countries hinders market growth in the region.
• Lack of clear understanding and knowledge about biotic ingredients globally is restricting market growth.

Table of Contents

Growth Environment: Transformation in the Biotic Ingredients Industry

• Why Is It Increasingly Difficult to Grow?
• The Strategic Imperative 8
• The Impact of the Top 3 Strategic Imperatives on the Biotic Ingredients Industry

Ecosystem in the Biotic Ingredients Industry

• What is the Microbiome?
• Role of Microbiome in Human Health
• Ecosystem of the Gut Microbiome Industry
• Scope of Analysis
• Segmentation by Ingredients
• Market Definitions: Biotic Ingredients
• Market Definitions: Probiotic Ingredients
• Market Definitions: Prebiotic Ingredients
• Market Definitions: Postbiotic Ingredients
• Application Definitions

Value Chain

Competitive Environment

Key Competitors

• Competitive Benchmarking: Probiotic Ingredients
• Competitive Benchmarking: Prebiotic Ingredients
• Competitive Benchmarking: Postbiotic Ingredients
• Probiotic Ingredients: Market Activities of Leading Manufacturers 2022-2024
• Prebiotic Ingredients: Market Activities of Leading Manufacturers 2022-2023
• Prebiotic Ingredients: Market Activities of Leading Manufacturers 2022-2024
• Postbiotic Ingredients: Market Activities of Leading Manufacturers 2023-2024

Growth Generator in the Biotic Ingredients Industry

• Growth Metrics
• Growth Drivers
• Growth Driver Analysis
• Growth Restraint
• Growth Restraint Analysis
• Spotlight on the Synbiotics Industry
• Market Trends
• Forecast Considerations
• Revenue Forecast
• Revenue Forecast by Product Category
• Revenue Forecast by Region
• Revenue Forecast by Asia-Pacific Country
• Pricing Analysis and Forecast Assumptions
• Competitive Landscape

Growth Generator: Probiotic Ingredients

• Growth Metrics
• Introduction to Probiotics
• Probiotics Value Chain
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Ingredient
• Revenue Forecast Analysis by Ingredient
• Revenue Forecast by Application
• Revenue Forecast Analysis by Application
• Revenue Forecast by Health Benefit
• Revenue Forecast Analysis by Health Benefit
• Revenue Forecast by Region
• Revenue Forecast by Asia-Pacific Country
• Revenue Forecast Analysis by Region

Growth Generator: Prebiotic Ingredients

• Growth Metrics
• Introduction to Prebiotics
• Understanding Dietary Fibers Vs Prebiotics
• Prebiotics Value Chain
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Ingredient
• Revenue Forecast Analysis by Ingredient
• Revenue Forecast by Application
• Revenue Forecast Analysis by Application
• Revenue Forecast by Health Benefit
• Revenue Forecast Analysis by Health Benefit
• Revenue Forecast by Region
• Revenue Forecast by Asia-Pacific Country
• Revenue Forecast Analysis by Region

Growth Generator: Postbiotic Ingredients

• Introduction to Postbiotics
• Postbiotics Value Chain
• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Application
• Revenue Forecast Analysis by Application
• Revenue Forecast by Ingredient
• Revenue Forecast by Health Benefit
• Revenue Forecast Analysis by Ingredient and Health Benefit
• Revenue Forecast by Region
• Revenue Forecast by Asia-Pacific Country
• Revenue Forecast Analysis by Region

Growth Opportunity Universe in the Biotic Ingredients Industry

• Growth Opportunity 1: Postbiotics as a Growth Product Category
• Growth Opportunity 2: Product Innovations in the Prebiotics Space
• Growth Opportunity 3: Expansion into a Wider Range of Therapeutic Areas

Appendix & Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• List of Exhibits
• Legal Disclaimer